Clinical Determinants of Coronary
Clinical Determinants of Coronary
Clinical Determinants of Coronary
Dissertation submitted to
The Tamil Nadu Dr. M.G.R Medical University, Chennai
in partial fulfillment of the requirements for the degree of
DM Cardiology
Branch II
August 2013.
CERTIFICATE
laid down by The Tamil Nadu Dr. M.G.R Medical University, Chennai,
Date :
I thank Nurses and technicians for their help rendered through out
the period of study.
“CLINICAL DETERMINANTS OF
CORONARY COLLATERALS”
AN ANGIOGRAPHIC STUDY
CONTENTS
S. Title Page
No. No.
1. INTRODUCTION 1
3. REVIEW OF LITERATURE 5
5. OBSERVATION 19
6. RESULTS 46
7. DISCUSSION 50
8. SUMMARY 58
9. CONCLUSION 62
BIBLIOGRAPHY
ABBREVIATIONS
PROFORMA
MASTER CHART
ETHICAL COMMITTEE APPROVAL ORDER
CONSENT FORM
ANTI PLAGIARISM ORIGINALITY REPORT
ABBREVIATIONS
ECG- electrocardiogram
ECHO- echocardiogram
developed countries and may become the most important reason for
1
depends on the adequacy of flow through the alternate coronary pathways
or coronary collaterals.
and between different coronary arteries (1). Collateral circulation has been
collaterals may minimize the infarct size and increase the amount of
studies for grading of collaterals in all the risk factors and clinical
fruitful wisdom.
3
AIMS AND OBJECTIVES
4
REVIEW OF LITERATURE
accounting for nearly 30% of all deaths worldwide6 .CAD has been
Coronary circulation
sinus gives off two major coronary arteries which subdivide on the
5
epicardial surface of heart. Left main coronary artery arises from left
aortic sinuses and right coronary artery arises from right aortic sinuses.
left main coronary artery after its origin, divides into anterior descending
and outside the coronary vascular bed. The control of coronary blood
endothelial control .7
Coronary Collaterals:
6
circulation is still not clear. In any arterial occlusion, affected organ may
who got nearly cured of his angina pectoris by sawing wood each day . 8
7
recruitment . Both mechanisms may probably contribute to the described
phenomenon.
8
functional (muscular) collateral arteries concomitant with acquisition of
vascular network . 12
vessel formation in the fetus does not play a significant role in adult
collateralization.
9
• terminal extension of two coronary arteries,
• ventricular septum
• ventricular apex
• cardiac crux,
• atrial surfaces.
10
• BL – bridging across
lesion
• AT – atrial
• SE - septal
• BR – branch to
branch in ventricular
free wall
when necessary.15
11
2. Duration of the ischaemia:
angina pectoris before acute MI and showed that longer the duration,
5. Myocardial sensitivity:
are released due to low oxygen levels. Buschmann & schaper suggested
12
that the growth of collaterals is not only dependent on ischemia, but also
Grading of collaterals:
without artificial vascular occlusion(8). But later it was modified and the
widely used method provides a score from 0–3 for recruitable collateral
13
MATERIALS AND METHODS
Chennai.
patients was obtained for performing the study. Inclusion and exclusion
I INCLUSION CRITERIA:
14
II EXCLUSION CRITERIA:
III METHODS:
1. Age group:
2. Risk factor:
coronary risk factor. The patients were evaluated for conventional risk
Family history of CAD, prior CAD, and sedentary lifestyle. The risk
15
factor was correlated with development of coronary collaterals on
3. Clinical Presentation:
The patients with coronary occlusion were assessed for the mode
4. Investigations:
group in whom ECG stress test was already done prior to coronary
angiography were assessed for the correlation of stress test positivity and
16
groups based on stage of stress test positivity by Bruce protocol for
5. Coronary angiogram:
6. The parameters for coronary collateral arteries were assessed for its
i. number,
17
On coronary angiogram, grading of coronary collateral was done
i. sex distribution
vi. LV function
18
OBSERVATION
total or subtotal occlusion of coronary artery formed the study group. The
1. Distribution of cases:
occlusion formed the cases. The cases were categorized according to the
19
Table: I Distribution of cases
1. 18 – 30 0
2. 31 – 40 6
3. 41 – 50 14
4. 51 – 60 19
5. 61 - 70 9
>70 2
Total no of cases 50
20
2. Sex distribution
21
Table: II Sex distribution among cases
Male Female
1. 18 – 30 0 0
2. 31 – 40 4 2
3. 41 – 50 8 6
4. 51 – 60 16 3
5. 61 - 70 8 1
6. >70 2 0
Total no of cases 38 12
22
Chart II
23
3. Distribution of clinical presentation:
were cross checked with case records present at Madras Medical College,
1. ST elevation MI 26
2. NON ST elevation 6
3. Unstable Angina 2
5. Recurrent CAD 6
Total 50
24
Chart III: Clinical presentation among cases
No. of Cases
Age in Recurrent
STEMI NSTEMI USA CSA Total
years CAD
31 - 40yrs 4 0 1 1 0 6
41 - 50yrs 7 3 1 2 1 14
51 - 60yrs 10 3 0 5 1 19
61 - 70yrs 5 0 0 1 3 9
> 70 0 0 0 1 1 2
Total 26 6 2 10 6 50
25
Chart IV: Clinical presentation among Male and Female
26
4. Risk factors:
27
5. Left ventricle function:
evaluate the left ventricle functional status. The patients were categorized
Normal 18
Mild Dysfunction 20
Moderate Dysfunction 12
28
Chart VI: LV dysfunction in coronary artery occlusion
6. STRESS TEST:
29
Table VI: No of cases in different stage of STRESS +ve test
STAGE I 4
STAGE II 4
STAGE III 2
Total 10
30
5. Description of coronary artery occlusion
were classified into single artery occlusion and multiple artery occlusion,
Single artery
LAD 19 9 28
LCX 6 2 8
RCA 8 1 9
Multiple artery
TOTAL 50
31
Chart VII: Distribution of single artery and multiple artery occlusion
32
6. Site of occlusion of coronary artery
Segment of
LAD LCX RCA
Coronary artery
Proximal 19 6 9
Middle 14 - 5
Distal 0 2 0
33
7. Coronary artery occlusion and grading of collateral
occluded, the artery from which the collaterals originated were studied
0%
16%
46%
Grade 0
Grade 1
Grade 2
Grade 3
38%
34
Table IX: LAD OCCLUSION AND COLLATERALS
LCX RCA 0 1 2 3
Proximal 0 1 4 14 4 7 9 0
Middle 0 1 4 9 1 6 7 0
Coronary
Homo Hetero Both GRADING
artery
LAD RCA 0 1 2 3
Proximal 0 3 0 3 1 2 3 0
Distal 0 0 0 2 0 1 1 0
35
Table XI: RCA OCCLUSION AND COLLATERALS
Coronary
Homo Hetero Both GRADING
artery
LAD LCX 0 1 2 3
0
Proximal 0 4 0 5 2 3 4
Middle 1 3 0 1 0 2 3 0
36
8. Collaterals and Age factors:
groups
Age group
S/No. Collateral grading
(Yrs)
0 1 2 3
1. 18 – 30 0 0 0 0
2. 31 – 40 0 3 3 0
3. 41 – 50 1 4 9 0
4. 51 – 60 4 7 8 0
5. 61 - 70 3 3 3 0
6. >70 0 2 0 0
Total no of
8 19 23 0
cases
37
Chart X: Age and collateral grading
38
Table XIII: Clinical presentation and collaterals
S/ Clinical Total no of
No. presentation GRADE OF COLLATERAL Cases
0 I II III
1. ST elevation MI 4 12 10 0 26
2. NON ST elevation 1 3 2 0 6
3. Unstable Angina 1 1 0 0 2
Chronic Stable
4. Angina 1 2 7 0 10
5. Recurrent CAD 1 1 4 0 6
Total 8 19 23 0 50
39
Chart XI: clinical presentation and grade of collaterals
40
9. Risk factors and collaterals:The collaterals established were raded
and correlated with variety of risk factor of the patients presented with at
Total
S/ GRADING OF
RISK FACTORS no of
No. COLLATERAL
cases
Isolated risk
factor
0 I II III
1 DM 3 6 1 0 10
2 SYSTEMIC HYPERTENSION 0 0 2 0 2
3 SMOKING 1 3 7 0 11
4 DYSLIPEDEMIA 0 0 0 0 0
5 PRIOR CAD 0 0 2 0 2
6 OBESITY 0
7 FAMILY HISTORY 0 0 1 0 1
8 SEDENTARY LIFESTYLE 0
9 NO RISK FACTOR 1 5 8 0 14
10 Multiple risk factors
3 5 2 10
8 19 23 0 50
41
Chart XII: Isolated risk factors and grade of collaterals
42
11. Collaterals and sex distribution
0 1 2 3
1. Male 6 14 18 0
2. Female 2 5 5 0
43
12. LV function:
Total No
S/No. COLLATERAL GRADING
of Cases
LV FUNCTION 0 I II III
Normal 3 7 8 0 18
Mild LV
3 7 10 0 20
dysfunction
Moderate LV
2 5 5 0 12
dysfunction
Severe LV
No cases reported
dysfunction
Total 8 19 23 0 50
44
Patients who had undergone stress test were observed for collaterals.
0 I II III
STAGE I 4 1 1 2 0
STAGE II 4 0 1 3 0
STAGE III 2 0 0 2 0
Total 10 1 2 7 0
45
RESULTS
presented to the hospital were in the age group of 51- 60yrs, followed by
41-50yrs (Table I). Among the 50 patients studied, 38 were males and 12
were females (Table II). Male predominantly (66%) presented in the age
group >50 yrs whereas female presented early in life in the age group of
41- 50 years (chart I), but in all age group male were more in number
(chart III). ACS occurred most commonly in the age group of 40-60yrs
CAD (12%) and unstable angina (4%) (chart III). Out of 26 patients with
Chronic stable angina occurred above the age group of 50yrs. Recurrent
46
(Chart IV). Unstable angina, CSA, recurrent CAD was more common in
(28%) without any known risk factors. 9 patients had two or more risk
47
were found only in 10% of the patient (Chart VII). LAD was the most
occlusion of other artery (Chart VIII). The other arteries occluded were
RCA AND LCX. In all the arteries occluded, proximal part of the artery
in 46% of the patient, grade I collaterals was noted in 38% of the patients,
no collaterals were noticed in 16% of the patients (Chart IX). Grade III
artery, the collaterals were from both homo and hetero type of collateral
(Table VII). LAD artery was the major contributor as collateral in both
LCX and RCA type of occlusion. In LAD artery occlusion, RCA was the
patients above 70yrs of age had Grade I collateral. Both male and female
48
observed in 70% of patients with CSA and 66% of patients with recurrent
mellitus. 50% of the patients with prior CAD had grade II collateral. Both
the patients with positive family history of CAD had grade II collaterals.
In patients with multiple risk factors, common collateral grade was Grade
have Grade 2 collateral (Table XII). 6 males and 2 females had Grade 0
who had stage 1 positive stress test. Among the 6 patients with stage 2 &
49
DISCUSSION
modes of presentation and risk factors, when detected early can reduce
source of blood supply forms vital as the presence of collaterals can delay
the golden period and decrease the morbidity and increase the viable
cardiac tissue.
development.
50
STEMI. STEMI presented commonly in the age group of 40-60yrs of
study were chronic stable angina, NSTEMI, recurrent CAD and unstable
The most common associated risk factor in our study was smoking.
Among male patients, 71% of them were smokers. 48% of the patients
patients. 18% of the patients had multiple risk factors. History of prior
hypertension was seen in 22% of cases and a positive family history was
occlusion, where 69% of patients had LAD artery occlusion and 25% had
right coronary artery occlusion19. In our study, 90% of the patients had
single artery occlusion, among the single artery occlusion, 62% of the
patients had LAD occlusion and 20% of the patients had RCA
group had 18% of patient with LCX involvement which is double the
51
incidence of study of Piek JJ et al where only 6% of the patient had left
RS etal ., study the proximal and mid portion of RCA was commonly
involved with least distal occlusion .21 In our study also proximal and mid
portion of RCA are the commonly involved and none of patients had
52
In our study group with LAD occlusion , collateral were seen in 85% of
none of the patients received only homocollaterals. RCA was the most
LAD and LCX. Only one patient out of 50 patients had Homo-collateral,
53
which was present in RCA occlusion. Most of the collaterals for RCA
collaterals and rest with grade II collaterals. two patients were in the age
collaterals ,whereas in the total study group grade 2 collaterals were the
common collateral.
Meir P et al. in a 10yr follow up study found that long term cardiac
54
increased functional collaterals.23 Mills JD and others found in animal
infarction.24
55
Abaci et al, 1999, observed that there were more number of
collaterals.25
grade 0 collaterals and 60% of the patients had Grade I collaterals. 10%
grade II collaterals.
factors. 92% of the patients had coronary collaterals. 57% had grade II
collaterals.
56
20% of our total study group had multiple risk factors. 30% of the
patients had grade 0 collaterals and 50% grade I collaterals. 20% had
not correlate between LV function as our patient did not present with
Grade III collaterals. Patients with Grade II and I collaterals did not have
flow through collateral dependent area. In our study patients with stage I
patients with stage II and III positive stress test had grade II collaterals,
suggesting that patients with grade II collaterals can have more tolerance
to exercise.
57
SUMMARY
development.
40-60yrs of age
58
¾ STEMI was the most common clinical presentation.
was evaluated. The risk factors were categorized into isolated risk
involved segment.
classification on angiography.
59
¾ Both homo and hetero collateral together were the mode of
Branches from LAD was most the most common collateral in RCA
occlusion
commonest collateral.
60
¾ In patients who were smokers, most of the patient had collaterals.
commonly seen.
collaterals.
61
CONCLUSION
LAD
62
BIBLIOGRAPHY
19. Piek JJ, van Liebergen RA, Koch KT, Peters RJ, David GK Clinical,
angiographic and hemodynamic predictors of recruitable collateral
flow assessed during balloon angioplasty coronary occlusion
26. Nicolau JC, Pinto MA, Nogueira PR, Lorga AM, Jacob JL, Garzon
SA The role of antegrade and collateral flow in relation to left
ventricular function post-thrombolysis.
MASTER CHART
Ejection
Coronary artery COLLATERALS fraction
Risk factor
S. Clinical Angio (EF)
Name Age Sex
N. diagnosis NO.
LAD LCX RCA Type Origin Grade
36
Dm/smo/
1. Suryanarayanan 58 M STEMI 1706 + HETERO LAD &RCA 2
Prior
N
2. Haridas nil 53 M USA/ 1839 + nil 0
48
3. Swadesi Dm/Smo/Dys 40 M STEMI 1665 + Hetero RCA 2
42
DM/SHT/
4. Gopinath 57 M STEMI 1573 + Hetero RCA 1
Prior CAD
46
Pakkirisamy Both homo and
5. Nil 60 M STEMI 1515 + LCX/LAD 1
hetero
46
6. Savithra DM 38 F STEMI 1751 + Hetero RCA 1
48
7. Ganesan DM 55 M STEMI 1800 + Both hetero/homo LAD 2
49
Both homo and
8. Suman SMO 48 M NSEMI 1764 + RCA/LAD 2
hetero
55
Both homo and
9. chandrasekaran nil 45 M CSA/ tmt + 1812 + LCX/RCA 2
hetero
55
10. Kala SMO 38 F STEMI 1857 + heterocollateral LAD 1
58
11. Ravi DM 45 M STEMI 1703 + + nil 0
38
12. Ruche SM/HT 65 F USA 1711 + heterocollateral RCA 2
36
13. Kumar DM 67 M CSA 1765 + Both hetero/homo LAD/RCA 2
46
14. Chitra NIL 62 F REC.CAD 1867 + Both hetero/homo RCA/LAD 1
48
15. Saravanan NIL 63 M STEMI 1550 + Both hetero/homo LAD 2
60
16. Ekambaram SMO 57 M STEMI 1729 + Both hetero/homo LAD 1
42
17. Sreenivas SMO 46 M CSA 1831 + nil 0
48
18. Gunasekarasn SMO/DM 48 M REC.CAD 1871 + heterocollateral RCA 2
56
19. Sundaram SMO/OBE 58 M STEMI 1864 + Both hetero/homo LAD 2
40
20. Narayanan SHT/DM 57 M CSA 1543 + + nil 0
48
21. Murugesan SMO/DM 53 M REC.CAD 1501 + Both hetero/homo LAD 1
50
22. Latha PRIOR CAD 69 F NIL 1509 + heterocollateral RCA 1
38
23. Hari SMO 37 M CSA 1753 + + Both hetero/homo LAD/LCX 2
56
24. Muniyammal DM/SHT 38 F STEMI 1821 + Both hetero/homo LAD 2
55
25. Kamakchi SHT/DM 46 F NSTEMI 1859 + nil 0
42
26. Chandran SMO 42 M STEMI 1653 + Both hetero/homo LAD/LCX 1
38
27. Ambikapathi SMO/DM 57 M USA 1622 + Both hetero/homo LCX 2
52
28. Durai SMO/DM 55 M STEMI 1576 + + nil 0
50
29. Rajkumar SMO 67 M CSA 1669 + Both hetero/homo LAD 1
56
30. Visalakshi DM 63 F REC.CAD 1798 + Both hetero/homo LCX/RCA 2
58
Conus branch
31. Dayadharan OBE/SMO 55 M STEMI 1799 + homocollateral 2
RCA
46
32. Sreenivasan FAM H/O 70 M NSTEMI 1798 + heterocollateral LCX 1
48
33. Murugaraj SMO 75 M STEMI 1551 + heterocollateral RCA 1
58
34. Meenal DM/SHT 42 F CSA 1534 + nil 0
55
35. Nagaraj SMO/DM 57 M REC.CAD 1653 + heterocollateral LAD 2
42
36. Laksmi OBE/SMO 68 F STEMI 1789 + heterocollateral LCX/RCA 1
46
37. Balu DM/SMO 63 M STEMI 1834 + Both hetero/homo LAD/OM 1
40
DM/FAMH/O/S
38. Chinraj 48 M STEMI 1823 + nil 0
HT
39. Ragupathi SMO/SHT M 39 NSTEMI 1799 + heterocollateral 1 56
PRIOR
43. Nagendrabau M 65 NSTEMI 1744 + heterocollateral 1 42
CAD/SMO
SMO/PRIOR
44. Veeraiya M 59 CSA 1894 + Both hetero/homo 1 50
CAD
REC.CAD
50. Rajui SMO/DM M 64 1644 + Both hetero/homo 2 48
ANGIOGRAPHIC PICTURES
ANGIOGRAPHIC PICTURES
PROFORMA
NAME: AGE: yrs SEX: M / F
IP NO:
ADDRESS:
PRESENTATION:
1.STEMI
2. NSTEMI
3.USA
4. CSA
5.RECURRENT CAD
DURATION OF CAD:
RISK FACTORS :
1. IGT 2. DM 3. SHT
9. SEDENTARY LIFESTYLE
INVESTIGATIONS:
HBA1C:
BL.UREA: Sr.CR:
TMT:
CORONARY ANGIOGRAM:
LMCA-
LAD-
LCX-
RCA-
ANGIOGRAPHIC DIAGNOSIS:
COLLATERALS:
NUMBER:
HOMOCOLLATERLS:
HETEROCOLLATERALS:
TYPESOF COLLATERALS:
GRADING OF COLLATERALS:
Informed consent form
Title of the study -
Name of the participant: ____________________________________________
Name of the Principal/Co-Investigator: _________________________________
Name of the Institution: _____________________________________________
Name and address of the sponsor / agency(ies), if any: _____________________
I,________(name of participant), have read the information in this form (or it has been read to
me). I was
free to ask any questions and they have been answered. I am over 18 years of age and,
exercising
my free power of choice, hereby give my consent to be included as a participant in ___ ” (title
of the study)
(1) I have read and understood this consent form and the information provided to me.
(2) I have had the consent document explained to me.
(3) I have been explained about the nature of the study.
(4) I have been explained about my rights and responsibilities by the investigator.
(5) I have informed the investigator of all the treatments I am taking or have taken in the past
______ months including any native (alternative) treatments.
(6) I am aware of the fact that I can opt out of the study at any time without having to give
any reason and this will not affect my future treatment in the hospital.
(7) I hereby give permission to the investigators to release the information obtained from me
as result of participation in this study to the sponsors, regulatory authorities, Government
agencies, and ethics committee. I understand that they may inspect my original records.
(8) I understand that my identity will be kept confidential if my data are publicly presented.
(9) I have had my questions answered to my satisfaction.
(10) I consent voluntarily to participate as a participant in the research study.
I am aware, that if I have any questions during this study, I should contact the
investigators. By signing this consent from, I attest that the information given in this
document has been clearly explained to me and understood by me. I will be given a copy of
this consent document.